Phenytoin potentiation of neuroleptic‐induced dyskinesias

K. D. Sethi, Ana Hitri, Bruce I. Diamond

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Clinically phenytoin‐induced movement disorders may resemble neuroleptic‐induced tardive dyskinesia (TD). Neuroleptic‐induced TD is thought to be related to an increase in the number and affinity of dopamine D2 receptors. We investigated the interaction of phenytoin with dopaminergic systems by measuring dopamine behavior and receptor changes in animals treated with phenytoin alone or in combination with chlorpromazine. Phenytoin alone or in combination produced significant behavioral supersensitivity without alteration of dopamine D2 receptor density or affinity. This animal study suggests that phenytoin may aggravate neuroleptic‐induced tardive dyskinesia through mechanisms other than the dopamine D2 receptors.

Original languageEnglish (US)
Pages (from-to)325-327
Number of pages3
JournalMovement Disorders
Volume5
Issue number4
DOIs
StatePublished - 1990

Fingerprint

Dyskinesias
Phenytoin
Dopamine D2 Receptors
Chlorpromazine
Dopamine Receptors
Movement Disorders
Tardive Dyskinesia

Keywords

  • Neuroleptic dyskinesias
  • Phenytoin

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Phenytoin potentiation of neuroleptic‐induced dyskinesias. / Sethi, K. D.; Hitri, Ana; Diamond, Bruce I.

In: Movement Disorders, Vol. 5, No. 4, 1990, p. 325-327.

Research output: Contribution to journalArticle

Sethi, K. D. ; Hitri, Ana ; Diamond, Bruce I. / Phenytoin potentiation of neuroleptic‐induced dyskinesias. In: Movement Disorders. 1990 ; Vol. 5, No. 4. pp. 325-327.
@article{e89e17b095a54343b87739b82642a0f2,
title = "Phenytoin potentiation of neuroleptic‐induced dyskinesias",
abstract = "Clinically phenytoin‐induced movement disorders may resemble neuroleptic‐induced tardive dyskinesia (TD). Neuroleptic‐induced TD is thought to be related to an increase in the number and affinity of dopamine D2 receptors. We investigated the interaction of phenytoin with dopaminergic systems by measuring dopamine behavior and receptor changes in animals treated with phenytoin alone or in combination with chlorpromazine. Phenytoin alone or in combination produced significant behavioral supersensitivity without alteration of dopamine D2 receptor density or affinity. This animal study suggests that phenytoin may aggravate neuroleptic‐induced tardive dyskinesia through mechanisms other than the dopamine D2 receptors.",
keywords = "Neuroleptic dyskinesias, Phenytoin",
author = "Sethi, {K. D.} and Ana Hitri and Diamond, {Bruce I.}",
year = "1990",
doi = "10.1002/mds.870050413",
language = "English (US)",
volume = "5",
pages = "325--327",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Phenytoin potentiation of neuroleptic‐induced dyskinesias

AU - Sethi, K. D.

AU - Hitri, Ana

AU - Diamond, Bruce I.

PY - 1990

Y1 - 1990

N2 - Clinically phenytoin‐induced movement disorders may resemble neuroleptic‐induced tardive dyskinesia (TD). Neuroleptic‐induced TD is thought to be related to an increase in the number and affinity of dopamine D2 receptors. We investigated the interaction of phenytoin with dopaminergic systems by measuring dopamine behavior and receptor changes in animals treated with phenytoin alone or in combination with chlorpromazine. Phenytoin alone or in combination produced significant behavioral supersensitivity without alteration of dopamine D2 receptor density or affinity. This animal study suggests that phenytoin may aggravate neuroleptic‐induced tardive dyskinesia through mechanisms other than the dopamine D2 receptors.

AB - Clinically phenytoin‐induced movement disorders may resemble neuroleptic‐induced tardive dyskinesia (TD). Neuroleptic‐induced TD is thought to be related to an increase in the number and affinity of dopamine D2 receptors. We investigated the interaction of phenytoin with dopaminergic systems by measuring dopamine behavior and receptor changes in animals treated with phenytoin alone or in combination with chlorpromazine. Phenytoin alone or in combination produced significant behavioral supersensitivity without alteration of dopamine D2 receptor density or affinity. This animal study suggests that phenytoin may aggravate neuroleptic‐induced tardive dyskinesia through mechanisms other than the dopamine D2 receptors.

KW - Neuroleptic dyskinesias

KW - Phenytoin

UR - http://www.scopus.com/inward/record.url?scp=0025089697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025089697&partnerID=8YFLogxK

U2 - 10.1002/mds.870050413

DO - 10.1002/mds.870050413

M3 - Article

C2 - 2147979

AN - SCOPUS:0025089697

VL - 5

SP - 325

EP - 327

JO - Movement Disorders

JF - Movement Disorders

SN - 0885-3185

IS - 4

ER -